Resultado de búsqueda
Hace 5 días · 22 days ago - GlobeNewsWire. RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients.
- 3.05
- 116.80M
- 271.42M
- 34.80M
Hace 4 días · RAPT Therapeutics Inc (RAPT) es una empresa biofarmacéutica que se dedica al desarrollo y comercialización de terapias innovadoras para el tratamiento del cáncer y enfermedades inflamatorias.
Hace 2 días · Should You Buy or Sell RAPT Therapeutics Stock? Get The Latest RAPT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (650) 489-9000
- 561 ECCLES AVENUE, SOUTH SAN FRANCISCO CA, 94080
- investors@rapt.com
Hace 5 días · Classificamos a RAPT4 como uma de nossas principais escolhas para 2024 (junto à POMO4), com nossa visão positiva apoiada por: (i) expectativas de recuperação do mercado para veículos pesados no Brasil após uma queda em 2023 pela transição Euro VI (apoiando melhores volumes esperados para sua divisão de Autopeças) e (ii) vendas promissoras do nov...
Hace 1 día · What do the trends say about RAPT Therapeutics? View the latest RAPT trend and sentiment data at MarketBeat.
Hace 5 días · Get RAPT Therapeutics Inc (RAPT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Hace 4 días · 24 days ago - RAPT Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire ; 7 weeks ago - RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients - GlobeNewsWire
